Natus Medical Inc (BABY) Files Form 4 Insider Selling : Kenneth M Traverso Sells 7,459 Shares

Natus Medical Inc (BABY): Kenneth M Traverso , VP/GM Newborn Care of Natus Medical Inc sold 7,459 shares on Apr 22, 2016. The Insider selling transaction was reported by the company on Apr 26, 2016 to the Securities and Exchange Commission. The shares were sold at $33.56 per share for a total value of $250,324.05 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Feb 18, 2016, Ken Ludlum (director) sold 6,625 shares at $33.01 per share price.On Dec 11, 2015, Dong Chune Christopher Chung (Vice President Medical Affairs) sold 14,000 shares at $48.78 per share price.Also, On Nov 30, 2015, Austin Francis Iii Noll (VP/GM Neurology) sold 38,875 shares at $48.40 per share price.On Nov 30, 2015, James B Hawkins (President and CEO) sold 57,511 shares at $49.01 per share price.

Natus Medical Inc: On Friday, Apr 22, 2016 heightened volatility was witnessed in Natus Medical Inc which led to swings in the share price. The shares opened for trading at $32.78 and hit $34.12 on the upside , eventually ending the session at $34.09, with a gain of 4.19% or 1.37 points. The heightened volatility saw the trading volume jump to 6,38,712 shares. The 52-week high of the share price is $51.05 and the company has a market cap of $1,130 M . The 52-week low of the share price is at $29.34.

Natus Medical Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.Natus Medical Inc is Downgraded by Raymond James to Mkt Perform. Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Apr 5, 2016.

Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.

Leave a Reply

Natus Medical Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Natus Medical Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.